Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001562180-21-005948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +61.0K | 62.0K | +6,052% | +$439.2K |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.11 | -61.0K | 17.7K | -78% | -$1.17M |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $0.00 | -61.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | M | A | 16,651 | $7.20 | 34,310 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 44,349 | $19.15 | 17,659 | D | — | — | (F3) The sale prices ranged from $19.00 to $19.31 |
| 3 | Common | Common Stock | 2021-09-14 | M | A | 44,349 | $7.20 | 62,008 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-13 | S | D | 16,651 | $19.02 | 17,659 | D | — | — | (F2) The sale prices ranged from $19.00 to $19.10 |
| 5 | Derivative | Stock Options (Right to buy) | 2021-09-13 | M | D | 16,651 | $0.00 | 0 | D | $7.20 · — to 2025-06-01 | 16,651 Common Stock | (F4) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2021-09-14 | M | D | 44,349 | $0.00 | 0 | D | $7.20 · — to 2025-06-01 | 44,349 Common Stock | (F4) This option is fully vested. |